{"title":"SARS-CoV-2 clearance after breakthrough infection correlates with fit and happy cells","authors":"Marc Veldhoen, Antonio Bertoletti","doi":"10.1111/imcb.12667","DOIUrl":null,"url":null,"abstract":"<p><i>Immunology & Cell Biology</i> 2023; <b>101</b>: 672; https://doi.org/10.1111/imcb.12667</p><p>Correction to: <i>Immunology & Cell Biology</i> 2023; https://doi.org/10.1111/imcb.12654</p><p>Conflicts of Interest were omitted from this article. This information appears below. The authors apologize for this error.</p><p>A Bertoletti reports a pending patent for a method to monitor SARS-CoV-2-specific T cells in biological samples. He is also co-founder and owns shares in (a) LION TCR, a biotech company developing T cell therapy against virus-related cancers, and (b) T-cell Diagnostic, a company providing immunological monitoring in clinical samples.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"101 7","pages":"672"},"PeriodicalIF":3.2000,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12667","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12667","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Correction to: Immunology & Cell Biology 2023; https://doi.org/10.1111/imcb.12654
Conflicts of Interest were omitted from this article. This information appears below. The authors apologize for this error.
A Bertoletti reports a pending patent for a method to monitor SARS-CoV-2-specific T cells in biological samples. He is also co-founder and owns shares in (a) LION TCR, a biotech company developing T cell therapy against virus-related cancers, and (b) T-cell Diagnostic, a company providing immunological monitoring in clinical samples.
期刊介绍：
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
